d-alpha tocopherol has been researched along with omeprazole in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baell, JB; Board, PG; Casarotto, MG; Dahlin, JL; Oakley, AJ; Xie, Y | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Groves, FD; Heinrich, JP; Hu, J; Jin, ML; Li, JY; Liu, WD; Ma, JL; Mark, SD; Rabkin, CS; Xu, GW; You, WC; Zhang, L | 1 |
| Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Heinrich, J; Liu, WD; Ma, JL; Xu, GW; Yang, CS; You, WC; Zhang, L | 1 |
| Chuang, CH; Huang, AH; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Postavnyĭ, VE | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Hu, Y; Jin, ML; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Xu, GW; You, WC; Zhang, L | 1 |
| Ariturk, E; Aydin, O; Ayyildiz, SH; Bernay, F; Bicakci, U; Kilicoglu-Aydin, B; Rizalar, R; Tander, B; Topaloglu, B | 1 |
| Ariturk, E; Aydin, O; Bernay, F; Bicakci, U; Cadir, FO; Kilicoglu-Aydin, B; Rizalar, R; Tander, B | 1 |
| Rao, CV; Vijayakumar, M | 1 |
| Chen, X; Hao, J; Hao, X; Lee, M; Liu, B; Reuhl, KR; Yang, CS; Zhang, B | 1 |
| Blot, WJ; Brown, LM; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Han, ZX; Hu, Y; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Shen, L; You, WC; Zhang, L | 1 |
| Huilgol, SV; Kumar, VH | 1 |
| Chang, HW; Chang, VHS; Chien, LN; Chu, PG; Dong, F; Jia, W; Lin, IH; Liu, YR; Wu, MJ; Xie, G; Yang, YSH; Yen, Y | 1 |
2 review(s) available for d-alpha tocopherol and omeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.
Topics: Drug Design; Drug Discovery; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorescence Polarization; Glutathione Transferase; Humans | 2018 |
6 trial(s) available for d-alpha tocopherol and omeprazole
| Article | Year |
|---|---|
Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Ascorbic Acid; China; Double-Blind Method; Drug Therapy, Combination; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Penicillins; Phytotherapy; Plant Extracts; Plants, Medicinal; Precancerous Conditions; Selenium; Stomach Neoplasms; Vitamin E | 1998 |
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
Topics: Adult; Aged; Amoxicillin; Antioxidants; Ascorbic Acid; beta Carotene; China; Double-Blind Method; Drug Therapy, Combination; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Phytotherapy; Plants, Medicinal; Precancerous Conditions; Prevalence; Selenium; Stomach Neoplasms; Treatment Outcome; Vitamin E | 2001 |
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lansoprazole; Male; Metronidazole; Omeprazole; Severity of Illness Index; Stomach Diseases; Treatment Outcome; Vitamin E | 2002 |
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Metronidazole; Middle Aged; Omeprazole; Tocopherols; Treatment Outcome | 2005 |
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Topics: Adult; Amoxicillin; Ascorbic Acid; China; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Garlic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Phytotherapy; Precancerous Conditions; Prevalence; Selenium; Severity of Illness Index; Stomach Neoplasms; Vitamin E | 2006 |
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; China; Confounding Factors, Epidemiologic; Dietary Supplements; Factor Analysis, Statistical; Female; Follow-Up Studies; Garlic; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Omeprazole; Precancerous Conditions; Proportional Hazards Models; Stomach Neoplasms; Vitamin E; Vitamins | 2012 |
7 other study(ies) available for d-alpha tocopherol and omeprazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biochemical and histopathologic effects of omeprazole and vitamin E in rats with corrosive esophageal burns.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Burns, Chemical; Disease Models, Animal; Drug Therapy, Combination; Esophagus; Glutathione; Hydroxyproline; Injections, Intramuscular; Injections, Intraperitoneal; Malondialdehyde; Omeprazole; Rats; Rats, Wistar; Treatment Outcome; Vitamin E | 2008 |
Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Ulcer Agents; Antioxidants; Disease Models, Animal; Drug Therapy, Combination; Enterocolitis, Necrotizing; Hypoxia; Injections, Intramuscular; Intestine, Small; Malondialdehyde; Omeprazole; Rats; Rats, Wistar; Spectrophotometry; Vitamin E; Xanthine Dehydrogenase; Xanthine Oxidase | 2008 |
Effect of quercetin, flavonoids and alpha-tocopherol, an antioxidant vitamin, on experimental reflux oesophagitis in rats.
Topics: alpha-Tocopherol; Animals; Antioxidants; Catalase; Collagen; Disease Models, Animal; Esophagitis, Peptic; Esophagus; Gastric Acid; Gastrointestinal Agents; Glutathione; Hexoses; Histamine; Lipid Peroxidation; Male; Malondialdehyde; Mucous Membrane; N-Acetylneuraminic Acid; Omeprazole; Oxidative Stress; Pepsin A; Proton Pump Inhibitors; Quercetin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2008 |
Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.
Topics: Acetylcysteine; Adenocarcinoma; alpha-Tocopherol; Animals; Disease Models, Animal; Esophageal Neoplasms; Gastroesophageal Reflux; Hydrogen-Ion Concentration; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Vitamin A | 2009 |
Evaluation of antiulcerogenic potential of antioxidant α-tocopherol in pylorus-ligated albino rats.
Topics: alpha-Tocopherol; Animals; Anti-Ulcer Agents; Antioxidants; Female; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Ligation; Male; Omeprazole; Pylorus; Rats; Severity of Illness Index; Stomach Ulcer | 2014 |
Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Bile Duct Neoplasms; Bile Ducts; Cell Transformation, Neoplastic; Cholangiocarcinoma; Cholestasis; Feces; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Omeprazole; Proton Pump Inhibitors; Rats, Wistar; Retinoid X Receptor alpha; RNA-Binding Proteins; RNA, Ribosomal, 16S; Tyrosine | 2020 |